|
|
Tolerance-programming biomaterial-based Intranasal ASIT for the treatment of autoimmunity |
| 1 DP2 AI164306-01 |
WILSON, DAVID SCOTT |
NIAID |
2021 |
|
|
Human antibody modification of enterovirus D68 infection |
| 1 K08 AI156125-01A1 |
VOGT, MATTHEW R |
NIAID |
2021 |
|
|
Development of thiophen-2-yl-phenylpyrimidines for treatment of schistosomiasis |
| 1 R21 AI156554-01A1 |
CAFFREY, CONOR |
NIAID |
2021 |
|
|
Use of use of dimethyl fumarate for targeting autoimmunity in type 1 diabetes |
| 1 R21 AI166368-01 |
BAYER, ALLISON LORAYNE |
NIAID |
2021 |
|
|
Development of an adaptable RNA vaccine against enterovirus D68 infection for the prevention of acute flaccid myelitis |
| 1 R43 AI165100-01 |
ERASMUS, JESSE HONG-SAE |
NIAID |
2021 |
|
|
A New Approach to Treat Prosthetic Joint Infections with a ClpP Activating Antibiotic |
| 1 R44 AI157081-01 |
LAFLEUR, MICHAEL |
NIAID |
2021 |
|
|
How Do a Few Attached Staphylococcus aureus Bacteria Evade Innate Immunity to Initiate Biofilm Infection on an Implanted Medical Device? |
| 1 R56 AI155692-01 |
STEWART, PHILIP S |
NIAID |
2021 |
|
|
Regulation of positive-stranded RNA virus infection by host factors of the endomembrane system |
| 5 K22 AI143963-02 |
LENNEMANN, NICHOLAS J |
NIAID |
2021 |
|
|
Innate Immune Response to S. aureus Biofilm |
| 5 P01 AI083211-13 |
KIELIAN, TAMMY L |
NIAID |
2021 |
|
|
Altered innate leukocyte programming dynamics in sepsis |
| 5 R01 AI136386-04 |
LI, LIWU |
NIAID |
2021 |
